SCARLETT JOHN A
Insider CIK 1270928 · CHMA Director · CTMX Director · GERN President, CEO and Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GERN GERON CORP | P Buy | 2025-02-27 | 2025-03-03 | 12,500 | $1.77 | $22.1K | 12,500 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2025-02-18 | 2025-02-20 | 410,000 | — | $0 | 410,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2025-02-18 | 2025-02-20 | 2,457,000 | — | $0 | 2,457,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-06-06 | 2024-06-07 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2024-06-04 | 2024-06-05 | 600,000 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise | 2024-06-04 | 2024-06-05 | 600,000 | $2.54 | $1.52M | 600,000 | SEC↗ |
| GERN GERON CORP | S Sale | 2024-06-04 | 2024-06-05 | 600,000 | $4.00 | $2.40M | 600,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-02-14 | 2024-02-16 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2023-08-15 | 2023-09-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2023-02-22 | 2023-02-24 | 1,750,000 | — | $0 | 1,750,000 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2023-02-10 | 2023-02-10 | 446,668 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | S Sale | 2023-02-10 | 2023-02-10 | 446,668 | $3.00 | $1.34M | 0 | SEC↗ |
| GERN GERON CORP | M Exercise | 2023-02-10 | 2023-02-10 | 446,668 | $1.50 | $670.0K | 446,668 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2023-02-09 | 2023-02-10 | 446,666 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise | 2023-02-09 | 2023-02-10 | 446,666 | $1.50 | $670.0K | 446,666 | SEC↗ |
| GERN GERON CORP | S Sale | 2023-02-09 | 2023-02-10 | 446,666 | $3.03 | $1.35M | 0 | SEC↗ |
| GERN GERON CORP | M Exercise deriv | 2023-02-08 | 2023-02-10 | 446,666 | — | $0 | 0 | SEC↗ |
| GERN GERON CORP | M Exercise | 2023-02-08 | 2023-02-10 | 446,666 | $1.50 | $670.0K | 446,666 | SEC↗ |
| GERN GERON CORP | S Sale | 2023-02-08 | 2023-02-10 | 446,666 | $3.08 | $1.38M | 0 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2022-02-16 | 2022-02-18 | 2,100,000 | — | $0 | 2,100,000 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 10,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer | 2021-08-05 | 2021-08-05 | 61,322 | — | $0 | 0 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2021-02-02 | 2021-02-04 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2020-06-17 | 2020-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2020-06-11 | 2020-06-12 | 13,000 | — | $0 | 13,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2020-02-12 | 2020-02-14 | 582,750 | — | $0 | 582,750 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2019-06-13 | 2019-06-17 | 13,000 | — | $0 | 13,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2019-01-30 | 2019-02-01 | 1,050,000 | — | $0 | 1,050,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2018-06-07 | 2018-06-11 | 13,000 | — | $0 | 13,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2018-01-31 | 2018-02-02 | 1,050,000 | — | $0 | 1,050,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2017-06-15 | 2017-06-19 | 13,000 | — | $0 | 13,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2017-02-09 | 2017-02-10 | 1,050,000 | — | $0 | 1,050,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2016-06-10 | 2016-06-14 | 28,000 | — | $0 | 28,000 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2016-06-09 | 2016-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2016-02-11 | 2016-02-12 | 600,000 | — | $0 | 600,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2015-03-13 | 2015-03-16 | 600,000 | — | $0 | 600,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2014-02-11 | 2014-02-12 | 1,340,000 | — | $0 | 1,340,000 | SEC↗ |
| GERN GERON CORP | P Buy | 2013-04-01 | 2013-04-01 | 50,000 | $1.03 | $51.5K | 125,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2013-02-13 | 2013-02-14 | 1,340,000 | — | $0 | 1,340,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2012-05-17 | 2012-05-18 | 505,000 | — | $0 | 505,000 | SEC↗ |
| GERN GERON CORP | A Award | 2012-01-24 | 2012-01-25 | 75,000 | $1.72 | $129.0K | 75,000 | SEC↗ |
| GERN GERON CORP | P Buy | 2012-01-24 | 2012-02-08 | 75,000 | $1.72 | $129.0K | 75,000 | SEC↗ |